Down Regulation of Cerebral Cortical ³H Imipramine Binding Sites During Chronic Antidepressant Treatment is Independent of the Central Serotonergic Innervation

References

• Garattini S., Samanin R. Biochemical hypothesis on antidepressant drugs: a guide for clinicians or a toy for pharmacologists?. Psychol. Med. 1988; 18: 287–304
   PubMed Web of Science ®Google Scholar
• Healy D., Leonard B. Monoamine transportation in depression: kinetics and dynamics. J. Affective Disorders. 1987; 12: 91–103
   PubMedGoogle Scholar
• Langer S., Schoemaker H. Effects of antidepressants on monoamine transporters. Prog. Neuro-Psychopharmacol & Biol. Psychiat. 1988; 12: 193–216
   Google Scholar
• Stockmeier C., Wellar K. In vivo regulation of the serotonin-2 receptor in rat brain. Life Science 1985; 38: 117–127
   Google Scholar
• Stahl S., Palagidou L. The pharmacology of depression: studies of neurotransmitter receptors lead the search for biochemical lesions and neuro drug therapies. Tips. 1986; 7: 349–354
   Google Scholar
• Suranyi-Cadotte B., Dam T., Quirion R. Antidepressant-anxiolitic interaction: decreased density of benzodiazepine receptors in rat brain following chronic administration of antidepressant. Eur. J. Pharmacol. 1984; 106: 673–675
   Google Scholar
• Antkiewicz-Michaluk L., Michaluk J., Rokosz-Pelc A., Marona-Lewicka D., Vetulani J. The effect of chronic imipramine and electroconvulsive- shock treatment on [3H]DADLE binding to cortical membranes of rats pretreated with chronic reserpine or 6-hydroxydopamine. Pharmacol. Biochem. & Behav. 1987; 26: 203–206
   Google Scholar
• Green A. R. Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters. Neuropharmacology 1987; 26: 815–822
   Google Scholar
• Vetulani J., Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP generating system in the limbic forebrain. Nature 1975; 257: 495–496
   PubMed Web of Science ®Google Scholar
• Langer S., Moret C., Raismian R., Dubocovich M., Briley M. High affinity 3H-Imipramine binding in rat hypothalamus; association with uptake of serotonin but not of norepinephrine. Science 1980; 210: 1133–1135
   PubMed Web of Science ®Google Scholar
• Stockert M., Veiga A., Butman S., de Robertis E. Pre- and postsynaptic localization of 3H-imipramine binding sites in rat cerebral cortex. J. Receptor Res. 1984; 4: 755–771
   PubMed Web of Science ®Google Scholar
• Rehavi M., Skolnick P., Paul S. M. Subcellular distribution of high affinity 3H-imipramine binding and 3H-serotonin uptake in rat brain. Eur. J. Pharmacol. 1983; 87: 335–339
   PubMed Web of Science ®Google Scholar
• Sette M., Ruberg M., Raisman R., Scatton B., Zivkovic B., Agid Y., Langer S. Z. [3H]imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotonergic neurons. Eur. J. Pharmacol. 1983; 95: 41–51
   PubMed Web of Science ®Google Scholar
• Stockert M., de Robertis E. Pre- and postsynaptic localization of 3H-imipramine binding sites: action of 5–7 dihydroxytryptamine and triton X-100 on subcellular fraction of rat brain. J. Receptor Res. 1986; 6: 283–295
   PubMed Web of Science ®Google Scholar
• Scott J. A., Crews F. T. Down regulation of serotonin2 but not of beta-adrenergic receptors during chronic treatment with amitryptiline is independent of stimulation of serotonin2 and beta-adrenergic receptors. Neuropharmacology 1986; 25: 1301–1306
   PubMed Web of Science ®Google Scholar
• Stockert M., Serra J., de Robertis E. Effect of olfactory bulbectomy and chronic amitryptiline treatment in rats. 3H imipramine binding and behavioral analysis by swimming and open field tests. Pharmacol. Biochem. & Behav. 1988; 29: 681–686
   PubMed Web of Science ®Google Scholar
• Stockert M., Buscaglia V., de Robertis E. Action in vivo of phosphatidylserine, amitryptiline and stress on the binding of [3H] imipramine to membranes of the rat cerebral cortex. Eur. J. Pharmacol. 1989; 160: 11–17
   Web of Science ®Google Scholar
• Soubrie P., Martin P., El Mestikawy S., Thiebot M. H., Simon P., Hamon M. The lesion of serotonergic neurons does not prevent antidepressant-induced reversal of escape failures produced by inescapable shocks in rats. Pharmacol. Biochem. & Behav. 1986; 25: 1–6
   Google Scholar
• Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• de Robertis E., Azcurra J. M., Fiszer S. Ultrastructure and binding capacity of junctional complexes isolated from rat brain. Brain Res. 1967; 5: 45–56
   Google Scholar
• Cotman C. W., Taylor D. Isolation and structural studies on synaptic complexes from rat brain. J. Cell Biol. 1972; 55: 696–711
   PubMedGoogle Scholar
• Cohen R. S., Blomerg F., Berzins K., Siekevitz P. The structure of post-synaptic densities isolated from dog cerebral cortex. J. Cell Biol. 1977; 74: 181–203
   PubMed Web of Science ®Google Scholar
• Sabato U., Aguilar J. S., de Robertis E. Benzodiazepine receptors in rat brain: Action of Triton X-100 and localization in relation to the synaptic region. J. Receptor Res. 1981; 2(2)119–133
   PubMed Web of Science ®Google Scholar
• Hallman H., Jonsson G. Neurochemical studies on central dopamine neurons. Regional characterization of dopamine turnover. Med. Biol. 1984; 62: 198–202
   Google Scholar
• Nagayama H., Hingtgen J., Aprison M. Post-synaptic action by four antidepressive drugs in an animal model of depression. Pharmacol & Behaviour. 1981; 15: 125–130
   PubMed Web of Science ®Google Scholar
• Laduron P. M., Robbyns M., Schotte A. 3H-desimipramine and 3H-imipramine binding are not associated with noradrenaline and serotonin uptake in the brain. Eur. J. of Pharmacol. 1982; 78: 491–493
   PubMed Web of Science ®Google Scholar
• Whitaker P., Vint C., Morin R. 3H-imipramine labels sites on brain astroglial cells not related to serotonin uptake. J. of Neurochem. 1983; 41: 1319–1322
   Google Scholar
• Kinnier W. J., Chuang D. M., Costa E. Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine. Eur. J. Pharmacol. 1980; 67: 289–294
   PubMedGoogle Scholar
• Arbilla S., Briley M., Cathala F., Langer S. Z., Pornin C., Raisman R. Parallel changes in [3H]-imipramine binding sites in cat brain and platelets following chronic treatment with imipramine. Brit. J. Pharmacol. 1981; 72: 154–155
   Google Scholar
• Briley M., Raisman R., Arbilla S., Casadamont M., Langer S. Z. Concomitant decrease in [3H]imipramine binding in cat brain and platelets after chronic treatment with imipramine. Eur. J. Pharmacol. 1982; 81: 309–314
   Google Scholar
• Brunello N., Barbaccia M. L., Chuang D. M., Costa E. Down regulation of β-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons. Neuropharmacology 1982; 21: 1145–1149
   PubMed Web of Science ®Google Scholar
• Brunello N., Chuang D. M., Costa E. Different synaptic location of mianserin and imipramine binding sites. Science 1982; 215: 1112–1115
   PubMed Web of Science ®Google Scholar
• Janowsky A., Okada F., Manier D. H., Applegate C. L., Sulser F. E., Steranka L. R. Role of serotonergic input in the regulation of the β-adrenergic receptor-coupled adenylate cyclase system. Science 1982; 218: 900–901
   Google Scholar
• Nimgaonkar V. L., Goodwin G. M., Davies C. L., Green A. R. Down regulation of β-adrenoceptors in rat cortex by repeated administration of desipramine, electroconvulsive shock and clenbuterol requires 5-HT neurones but not 5-HT. Neuropharmacology 1985; 24: 279–283
   PubMed Web of Science ®Google Scholar
• Clements-Jewery S., Robson P. A. Intact 5HT neuroterminals are not required for 5HT2 receptor down-regulation by amitriptyline. Neuropharmacology 1982; 21: 725–727
   Google Scholar
• Sinhababu A. K., Borchardt R. T. Molecular mechanism of biological action of the serotonergic neurotoxin 5,7-dihydroxytryptamine. Neurochem. Int. 1988; 3: 273–284
   Google Scholar